Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/13/2012 | WO2012170828A1 Combination peptide-nanoparticles and delivery systems incorporating same |
12/13/2012 | WO2012170796A1 Gel compositions |
12/13/2012 | WO2012170785A1 Anti-cd22 antigen binding molecules to treat lung cancer and prostate cancer |
12/13/2012 | WO2012170677A1 Methods of treatment |
12/13/2012 | WO2012170676A1 Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration |
12/13/2012 | WO2012170655A1 Silk compositions and methods of using same |
12/13/2012 | WO2012170611A1 Multiparticulate 5-htp compositions and related methods |
12/13/2012 | WO2012170591A2 Hybrid polymer stent fabricated by a non-laser cut fabrication method |
12/13/2012 | WO2012170547A1 Bioadhesive drug delivery compositions |
12/13/2012 | WO2012170504A2 Treatment of extracellular matrix to reduce inflammation |
12/13/2012 | WO2012170334A2 Dressings and related methods therefor |
12/13/2012 | WO2012170061A1 Formulations of (r)-1-(2,2-diflurobenzo[d][1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methyl propan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide |
12/13/2012 | WO2012169973A1 A core-shell nanoparticle |
12/13/2012 | WO2012169972A1 Core-shell microspheres |
12/13/2012 | WO2012169736A2 Patch for transdermal delivery of composition and manufacturing method thereof |
12/13/2012 | WO2012169677A1 Composition for controlling gastric retention and release |
12/13/2012 | WO2012169662A1 Freeze-dried aripiprazole formulation |
12/13/2012 | WO2012169661A1 Monatin polyvalent metal salt crystal |
12/13/2012 | WO2012169614A1 Method for producing orodispersible tablets |
12/13/2012 | WO2012169600A1 Amino acid composition |
12/13/2012 | WO2012169518A1 Liquid composition, and cosmetic and hair growth agent each comprising same |
12/13/2012 | WO2012169435A1 Freeze-dried preparation containing high-purity pth and method for producing same |
12/13/2012 | WO2012169417A1 Film-like anesthetic drug |
12/13/2012 | WO2012168891A1 Process for the preparation of a metal complex in an oily organic matrix |
12/13/2012 | WO2012168882A1 Compositions and methods for improving stability and extending shelf life of sensitive food additives and food products thereof |
12/13/2012 | WO2012168392A1 Hydrogelator with shape-memory properties |
12/13/2012 | WO2012168189A1 Carotenoid coloring composition |
12/13/2012 | WO2012168144A1 Core-shell capsules |
12/13/2012 | WO2012167878A1 Edible oral strip or wafer dosage form containing ion exchange resin for taste masking |
12/13/2012 | WO2012167870A1 Treatment of cancers and metastases with suspensions of cilengitide in carrier |
12/13/2012 | WO2012167606A1 Pyridonaphthyridine pi3k/mtor dual inhibitors and preparation and use thereof |
12/13/2012 | WO2012167368A1 Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism |
12/13/2012 | WO2012167350A1 Method for the synthesis of porphyrin-phospholipid conjugates |
12/13/2012 | WO2012149268A8 Tolerogenic synthetic nanocarriers for allergy therapy |
12/13/2012 | WO2012143608A3 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract |
12/13/2012 | WO2012131412A3 Pharmaceutical composition containing no, process for the preparation and use thereof |
12/13/2012 | WO2012105816A3 Composition for preventing and treating diabetes and diabetes complications comprising amphicarpaea edgeworthii var. trisperma powder or an extract thereof |
12/13/2012 | WO2012101639A3 Nanoparticles based for dermal and systemic delivery of drugs |
12/13/2012 | WO2012101638A3 Nanoparticles based on poly (lactic glycolic) acid for cosmetic applications |
12/13/2012 | WO2012094653A3 Compositions and methods for macromolecular drug delivery |
12/13/2012 | WO2012021415A3 Oral compositions comprising a zinc compound and an anti-microbial agent |
12/13/2012 | US20120316517 Wound dressing containing foam and ointment base and swelling agent for negative pressure therapy |
12/13/2012 | US20120316244 Pharmaceutical Formulations of Modafinil |
12/13/2012 | US20120316229 Oral antimicrobial pharmaceutical compositions |
12/13/2012 | US20120316228 Oral antimicrobial pharmaceutical compositions |
12/13/2012 | US20120316189 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients diagnosed or undiagnosed respiratory illness |
12/13/2012 | US20120316180 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
12/13/2012 | US20120316179 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
12/13/2012 | US20120316134 Anaesthetic composition |
12/13/2012 | US20120315337 Multiparticulate 5-htp compositions and related methods |
12/13/2012 | US20120315336 Injectable nanoparticulate olanzapine formulations |
12/13/2012 | US20120315335 Self-assembling nanoparticle drug delivery system |
12/13/2012 | US20120315334 Pharmaceutical or neutraceutical formulation |
12/13/2012 | US20120315333 Direct inkjet fabrication of drug delivery devices |
12/13/2012 | US20120315332 Pharmaceutical composition including sunflower extract, preparative method and use thereof |
12/13/2012 | US20120315331 Pharmaceutical composition for the treatment of acute disorders |
12/13/2012 | US20120315330 Pharmaceutical composition for the treatment of acute disorders |
12/13/2012 | US20120315329 Siloxane surface-modified hydrogel and hydrogel microparticle compositions |
12/13/2012 | US20120315328 Capsule of compound danshen dripping pills |
12/13/2012 | US20120315327 Anti-diabetic composition containing a plant extract of englerina lecardii |
12/13/2012 | US20120315326 Multiparticulate l-carnitine compositions and related methods |
12/13/2012 | US20120315325 Peptide pharmaceutical for oral delivery |
12/13/2012 | US20120315324 Exosomal compositions and methods for the treatment of disease |
12/13/2012 | US20120315323 Influenza hemagglutinin antibodies, compositions and related methods |
12/13/2012 | US20120315322 Nanoparticle mediated gene therapy and therapeutic products for alzheimers |
12/13/2012 | US20120315321 Immunological methods and compositions for the treatment of alzheimer's disease |
12/13/2012 | US20120315320 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells |
12/13/2012 | US20120315319 Guided bone regeneration membrane and manufacturing method thereof |
12/13/2012 | US20120315318 Transdermal preparation |
12/13/2012 | US20120315315 Foam Formulations Containing at Least One Triterpenoid |
12/13/2012 | US20120315313 Liquid-filled chitosan-anionic liposoluble surfactant capsule dispersions |
12/13/2012 | US20120315311 Antiviral composition and method of use |
12/13/2012 | US20120315310 Bone tissue implant comprising lithium ions |
12/13/2012 | US20120315309 Modified pectins, compositions and methods related thereto |
12/13/2012 | US20120315308 Methods and devices for controlling particle size and particle size distribution |
12/13/2012 | US20120315307 Cell cultivation in chitosan alginate hydrogel beads |
12/13/2012 | US20120315306 Pharmaceutical composition and preparation for oral administration |
12/13/2012 | US20120315305 Dry Powder Fibrin Sealant |
12/13/2012 | US20120315304 Sensitization of immune system against haptenized melanoma antigens |
12/13/2012 | US20120315303 Methods and intravascular treatment devices using paclitaxel for treatment of atherosclerosis |
12/13/2012 | US20120315302 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
12/13/2012 | US20120315301 Preparation of vesicle-type carbon nanotubes |
12/13/2012 | US20120315300 Insertable medical devices with a porous bed for delivering nano-carriers to a target site and methods of preparing the same |
12/13/2012 | US20120315299 Pharmaceutical composition for intracellular acidification with cis-urocanic acid |
12/13/2012 | US20120315221 Human sample matching system |
12/13/2012 | US20120315219 Drug Delivery Coating For Use With A Stent |
12/13/2012 | US20120315218 Toxicology and Cellular Effect of Manufactured Nanomaterials |
12/13/2012 | US20120312312 Solid oral sensorial products including stain inhibitor |
12/13/2012 | DE212010000186U1 Bakterizides Sorptionsmaterial Bactericidal sorbent |
12/13/2012 | CA2838604A1 Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism |
12/13/2012 | CA2838589A1 Edible oral strip or wafer dosage form containing ion exchange resin for taste masking |
12/13/2012 | CA2838573A1 Treatment of cancers and metastases with suspensions of cilengitide in carrier |
12/13/2012 | CA2838529A1 Methods of treatment |
12/13/2012 | CA2838311A1 Compositions and methods for improving stability and extending shelf life of sensitive food additives and food products thereof |
12/13/2012 | CA2838065A1 Dressings and related methods therefor |
12/13/2012 | CA2838063A1 Cleavable lipids |
12/13/2012 | CA2837901A1 Method for the synthesis of porphyrin-phospholipid conjugates |
12/13/2012 | CA2837693A1 Freeze-dried aripiprazole formulation |
12/13/2012 | CA2837559A1 Oil dispersion of sulfoximines for the control of insects |
12/13/2012 | CA2837479A1 Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |